Skip to main content
. 2012 Apr 9;2012:497302. doi: 10.1155/2012/497302

Table 3.

Effect of ULEtOH on the concentration (ng/g tissue) of monoamines and their metabolites in the hippocampus of mice brain.

Groups Hippocampus (ng/g tissue)
NE MHPG DA DOPAC 5-HT 5-HIAA
Normal 581.57 ± 25.89 640.84 ± 44.27 713.98 ± 27.06 639.43 ± 49.15 638.07 ± 31.74 613.67 ± 78.51
Control versus FST 183.67 ± 24.01# 210.34 ± 22.72## 275.21 ± 34.86## 268.46 ± 26.14 113.72 ± 25.71### 192.77 ± 15.70##
Imipramine 10 mg/kg 851.76 ± 96.22*** 682.1 ± 31.39*** 633.56 ± 63.63 445.35 ± 94.67 898.71 ± 35.47*** 1028.46 ± 75.43***
ULEtOH 0.125 g/kg 431.38 ± 52.01 386.16 ± 27.86 435.43 ± 63.16 360.87 ± 107.15 201.48 ± 73.29 354.73 ± 91.78
ULEtOH 0.25 g/kg 510.95 ± 52.67** 515.38 ± 97.48** 539.59 ± 72.49 432.42 ± 67.79 229.74 ± 55.82 509.97 ± 44.55*
ULEtOH 0.5 g/kg 824.21 ± 71.69*** 735.31 ± .84*** 612.29 ± 84.59 532.09 ± 42.28 381.89 ± 10.25** 665.73 ± 42.55**

Value were the mean ± SEM (n = 6). # P < 0.05, ## P < 0.01, ### P < 0.001 as compared with the normal group.

*P < 0.05,**P < 0.01,***P < 0.001 as compared with the control group (one-way ANOVA following by Bonferroni's test).

HHS Vulnerability Disclosure